Ibraheem El Ghrably
Cyrus Tang and Lee Jampol Professor of Ophthalmology, Feinberg School of Medicine,
Dr. Fawzi is a vitreoretinal surgeon and clinician-scientist, Professor in the Department of Ophthalmology. She divides her time between her clinical/surgical practice and her NIH-Funded research at Northwestern University.
At Northwestern University, Dr. Fawzi runs an active NIH-funded translational research laboratory. Her lab studies animal models of ischemic retinopathies and her clinical research focuses on novel functional retinal imaging approaches including OCT angiography, visible-light OCT and hyperspectral imaging. Recognized for her imaging research, Dr. Fawzi serves on the Editorial Boards of Scientific Reports (Nature), Retina Journal and Investigative Ophthalmology and Visual Sciences, as well as serving on several NIH study sections. She has authored/coauthored over 160 peer-reviewed articles, has delivered several named Lectureships and has been elected as member of the Retina and Macula Societies. She has received the Honor Award of the American Society of Retina Specialists and the Achievement Award of the American Academy of Ophthalmology.
Careen Lowder has been a member of the Professional Staff of the Cleveland Clinic Cole Eye Institute since 1986 when she started the Uveitis Service in the Department of Ophthalmology. She obtained her MD (1978) and PhD (1975) degrees from Case Western Reserve University in Cleveland, Ohio. She completed her residency in ophthalmology at the Cleveland Clinic (1982) and a fellowship in uveitis at the FI Proctor Foundation at University of California San Francisco (1982-1984) and a fellowship in Ophthalmic Pathology at University of California San Francisco Department of Ophthalmology (1983-1984).
She received the Life Achievement Honor Award from the American Academy of Ophthalmology in 2016, and she is a frequent recipient of the Teacher of the Year award at the Cleveland Clinic Cole Eye Institute, most recently for 3 consecutive years (2015, 2016, 2017). She has been on the Best Doctors of America list every year since 1996 – 2019. She has over 175 peer review publications and is recognized as a leader in her field of uveitis. She was the Principal Investigator in numerous clinical trials and was the first author of the report on the dexamethasone implant trial.
Dr. Lowder served as president of the Cleveland Ophthalmological Society (2001 – 2003), as president of the Panamerican Society of Ocular Inflammatory Diseases from 1999 – 2012 and she is now the Executive Secretary of the Society. She served as Vice President of the International Uveitis Study Group and is currently a member of the International Council of the International Ocular Inflammation Society.
Daniel F. Martin, MD is Chair of the Cleveland Clinic Cole Eye Institute, the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology, and Professor of Ophthalmology in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Martin completed medical school at The Johns Hopkins University School of Medicine followed by residency and chief residency in ophthalmology at Emory University School of Medicine. He completed a fellowship in Vitreoretinal Surgery and Diseases at Duke University Eye Center followed by a two-year fellowship in Uveitis and Ocular Immunology at the National Eye Institute of the National Institutes of Health.
Dr. Martin currently serves as the Network Chair for the DRCR Retina Network. Dr Martin previously served as the Study Chair for the Comparison of AMD Treatments Trials (CATT) and has served as Study Chair for many other national clinical trials including those that led to FDA approval of the ganciclovir implant and valganciclovir. He has served as PI, member of the DSMC, and/or member of the Steering Committee for dozens of other studies including AREDS, SOCA, and MUST. He has published more than 200 peer-reviewed articles, delivered 38 named lectures, and delivered more than 370 invited lectures. Dr. Martin has been the recipient of numerous awards including the 74th Edward Jackson Memorial Lecture, the Heed-Gutman Award, the Gass Medal, the Roger Johnson Award in AMD Research, the Pyron Award, the Crystal Apple Award, the Rosenthal Award, the Sam and Maria Miller Award for Scientific Achievement in Clinical Research, and the Cless Medal. Dr Martin has previously served on the Board of Governors for the Cleveland Clinic.
Justis P. Ehlers, MD serves the Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research at the Cole Eye Institute of the Cleveland Clinic. He is also the Director of the Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research at the Cleveland Clinic. He earned his medical degree at the Washington University School of Medicine in St. Louis, Missouri, and completed his ophthalmology residency at the Wills Eye Institute in Philadelphia, Pennsylvania, where he served as Chief Resident. Dr. Ehlers then held a vitreoretinal surgery fellowship at the Duke Eye Center in Durham, North Carolina as a Heed Fellow and Ronald G. Michels Fellow. Since 2010, he has been at the Cole Eye Institute at the Cleveland Clinic where his laboratory focuses on translational intraoperative optical coherence tomography (OCT) technology, image-guided surgery, and advanced image analysis. He has co-authored over 150 peer-reviewed publications, 11 book chapters, and over 190 scientific abstracts. He has also been the senior editor for 2 books and given over 75 invited lectures. His work in translational imaging technology has resulted in multiple patents. Dr. Ehlers’ lab has become a leading center for intraoperative OCT, higher order image analysis for clinical trials and advanced assessment of ophthalmic diagnostics. Dr. Ehlers has received numerous awards including the ASRS Senior Honor Award, Cleveland Clinic Innovator Awards, and an AAO Achievement Award. Dr. Ehlers was recently recognized as one of the Top 40 Ophthalmologist Under 40, ranked #6 in the world. He currently serves on the AAO Vitreoretinal OTA Committee and previously served on the AAO Vitreoretinal COMPASS Knowledge Base Panel. He also serves on the ASRS Board of Directors and on the AAO Council.
Sunil K. Srivastava, MD, is a vitreoretinal staff physician at the Cleveland Clinic Cole Eye Institute. He received his medical degree from State University of New York at Buffalo School of Medicine and completed his ophthalmology residency at Emory University Hospital and School of Medicine, in Atlanta, Georgia. He later held a uveitis/medical retina fellowship at the National Institutes of Health in Bethesda, Maryland, and a fellowship in vitreoretinal surgery at Duke University Medical Center in Durham, North Carolina.
Dr. Mahmoud is a professor of Ophthalmology at Oakland University William Beaumont School of Medicine. He moved from North Carolina in 2017 where he was a tenured associate professor of Ophthalmology at Duke and the program director of the vitreoretinal surgery fellowship at the Duke University Eye center. He developed many surgical techniques including the first human autologous retinal transplantation, and the injection of subretinal air to displace submacular hemorrhage. He also introduced chandelier buckles to the United States and developed the ILM retracting door technique for macular holes. In 2019, he developed the nanovitreoretinal surgery platform.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He has been invited as a guest speaker all over the world, delivered many named lectures, and runs many surgical courses worldwide. He received many awards over the years, including the "Senior Honor Award" from the American Society of Retina Specialists, the prestigious Robert A. Machemer award from the Duke Eye Center, the "Distinguished Teacher of the Year Award" from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices and was the program director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011. Wayne State University-Kresge Eye Institute established the "Tamer H. Mahmoud, MD endowed fellowship research award" in 2012.
Dr Abboud did a first residency in Ophthalmology at the Quinze-Vingts National Ophthalmology center in Paris from 1983-1986, and then a second residency at the University of Chicago 1986-1989. He was the Chief Resident the last 18 months of his residency. He then proceeded to Wills Eye Hospital in Philadelphia where he completed a two year fellowship in Diseases and Surgery of the Retina and Intraocular Tumors. He became a diplomate of American Board of Ophthalmology in 1991. Dr Abboud then joined the Vitreoretinal Division at the King Khaled eye Specialist Hospital KKESH for a professional journey which lasted 22 years. He served as the Chief of the Vitreoretinal division from 1996 to 2008, Associate Medical Director from 1999 to 2007, and then the Medical Director from 2007-2010. Dr Abboud is also a passionate teacher, whereby during his tenure there, he trained more than 30 vitreoretinal Specialist, mainly from Saudi Arabia, but also from Kuwait, Bahrain and the UAE. Dr Abboud has over 50 peer reviewed publications, most notable of which is the reporting of a completely new disease, and identifying its genetic mutation. For this, he received the Best Research Award from the Saudi Ophthalmological Society in March 2013. Dr Abboud joined the Eye Institute at Cleveland Clinic Abu Dhabi in November 2013, and has served since then as Consultant and Chairperson for the Posterior Segment department.
Francesco Pichi, MD, is an Associate Staff Physician in the Eye Institute at Cleveland Clinic Abu Dhabi, who subspecializes in diseases of the retina, uveitis, ocular inflammations and infections. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Pichi worked at the Cole Eye Institute at Cleveland Clinic, Ohio, US.
Dr. Pichi’s experience in both Europe and the US has contributed to his diverse expertise in disease presentations in the fields of retina and uveitis. His clinical and research work has contributed to innovations in the fields of retinal imaging and the treatment of inflammatory eye diseases. He was part of the European Study Group that discovered the application of mineralocorticoid receptors antagonists for the oral treatment of central serous chorioretinopathy. He was also a leader in employing a non-invasive new imaging modality, such as Optical Coherence Tomography Angiography, to assess the status of the iris vessels in patients with vascular diseases such as hypertension, diabetes and vasculitis.
Dr. Pichi graduated summa cum laude from the Alma Mater Studiorum of the University of Bologna, Bologna, Italy and went on to pursue his Ophthalmology residency at the University of Milan, Milan, Italy, where he trained in Cataract Surgery. During his training, he developed an interest in the fields of medical retina and uveitis, and completed his internship at Moorfields Eye Hospital, London, UK.
He underwent a preceptorship in Uveitis and Ocular Immunology at Bascom Palmer Eye Institute, University of Miami, US. He also pursued a two-year fellowship at the Cole Eye Institute, Cleveland Clinic, Ohio, US in uveitis, ocular inflammations and infections.
His current research interest is the use of multimodal imaging of the retina in order to understand the etiology of various pathologies and to accurately guide treatment. In the fields of uveitis and ocular inflammation, his efforts are in creating objective ways of measuring inflammation, which would provide a better outcome for patients.
Dr El-Ghrably, MS, PhD, FRCOphth is a staff physician in the eye institute at Cleveland clinic Abu Dhabi. Prior to joining Cleveland clinic Abu Dhabi he was a consultant retina specialist at James Cook University Hospital, Middlesbrough, UK.
He has a special interest in medical and surgical retinal disorders. He did large number of ocular surgeries including: 3000 phacoemulsification with intraocular lens and nearly 800 of Vitreoretinal surgeries. He was actively involved in research and been awarded a PhD degree from Nottingham University, UK in 2000. He was the principle investigator for some clinical trials e.g MERLOT , Inject and Comrade clinical trials at JCUH. He has published widely and regularly invited as a speaker in many national and international conferences.
Dr El-Ghrably was the Royal College tutor for the department of ophthalmology, at James Cook University Hospital, also he was the educational and clinical supervisor for specialty trainee doctors. He was the Research and Development (R&D) lead for the division of surgery in JCUH for a while and was the Ophthalmology representative for North East Local Eye Health Network (LEHN). Also he was the Founder of Northern Regional Annual Audit meeting and a member of royal college, UK national committee for requirement of specialist trainees.
In April 2012 he received the NHS Clinical Excellence Award from JCUH as recognition for his excellent clinical service and his contribution in: teaching, training and research. And in January 2000 he had Nottingham University research prize for his PhD project.
Dr El-Ghrably is currently a fellow of the Royal college of Ophthalmology (RCOphth), UK, a member of the American Academy Of Ophthalmology (AAO) USA , a member of the Euretina and registered with General Medical Council (GMC), UK.
Piergiorgio Neri, MD, PhD, FEBOphth is an Associate Staff Physician in the Eye Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Neri was Assistant Professor of Ophthalmology at the Polytechnic University of Marche-Ancona.
Dr. Neri received his medical degree from University of Ancona Medical School, Italy. He completed His residency at University of Ancona Medical School.
Dr Neri was Honorary Research Fellow in Uveitis at the Eye Department, University of Aberdeen, scientist visitor at the University of Tübingen and Visiting Professor at Moorfields Eye Hospital in London. In 2010 he was named Assistant Professor of Ophthalmology at the Polytechnic University of Marche-Ancona.
Dr Neri was Medical Retina Consultant and Clinical Ocular Immunology Consultant and at the Ospedali Riuniti “Umberto I-GM Lancisi-G Salesi” of Ancona. He was director of the Ocular Immunology Service at the Ospedali Riuniti “Umberto I-GM Lancisi-G Salesi” of Ancona since 2007.
Dr Neri is member of the International Ocular Inflammation Society (IOIS), the European Society of Retina Specialists (EURETINA), International Uveitis Study Group (IUSG) and the European Association for Vision and Eye Research (EVER). Dr Neri has served EVER as Section Program Secretary for Immunology/Microbiology Section since 2010 and became Section President in 2016.
Dr Neri is also listed in the panel of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicine Agency (EMA) and of Italian Pharmaceutical Agency (AIFA).
Arif O. Khan MD is Consultant in Pediatric Ophthalmology & Strabismus and in Ocular Genetics at Cleveland Clinic Abu Dhabi and is Professor of Ophthalmology at Cleveland Clinic Lerner College of Medicine. Previously, until the end of 2015, he was Senior Academic Consultant at the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, and Senior Scientist at the King Faisal Specialist Hospital & Research Center, also in Riyadh. Before he moved to the Gulf region in January 2002, Dr. Khan was in private practice in New York. Dr. Khan's clinical and research interests are the management and genetics of ocular developmental disorders and strabismus. He is a frequent presenter at international ophthalmology meetings and has authored hundreds of scientific publications related to his field. Dr. Khan is Editor for the American Academy of Ophthalmology Basic and Clinical Science Course book on Pediatric Ophthalmology & Strabismus (BCSC Section 6) and Editorial Board member for journal Ophthalmic Genetics. Previously, he served as International Consultant for the American Academy of Ophthalmology curriculum in Pediatric Ophthalmology & Strabismus, Editorial Board member for the Journal of AAPOS, and Associate Editor for the Journal of AAPOS.